Labiotech.eu

Antoine Papiernik Sofinnova Partners Biotech Entrepreneurs

Opinion 7 Jul 2021

Three Lessons an Investor Can Learn from Biotech Entrepreneurs

Sofinnova Partners’ Chairman and Managing Partner, Antoine Papiernik, describes his company’s ‘Wall of Fame’ showcasing its entrepreneurs and how their years of experience provide a source of inspiration for venture capitalists. Every time I walk through our Paris office, I am greeted by a wall of photos showcasing some of the top entrepreneurial minds that […]

July 7, 2021 - 7 minutesmins - By Antoine Papiernik

Expert Advice 5 Jul 2021

Why the Right Team is Key for Biotech Success

For any startup, and especially for biotechnology startups, success depends on three main factors: science, financing, and people. One of the key factors investors look for is having a management team that can raise money and make good use of it to advance the science of the company. According to Sinclair Dunlop, Managing Partner at […]

July 5, 2021 - 7 minutesmins - By External Contributor

poxel diabetes Sumitomo Dainippon Pharma

News and Trends 2 Jul 2021

Poxel’s Diabetes Drug Wins Japan Nod, But Competition Remains Fierce

As French biotech Poxel marks the first market approval of its oral type 2 diabetes medication in Japan, eyes turn to the future of this drug and its rivals in Europe and the US. The fortunes of the Lyon-based Poxel have been boosted by the first-ever regulatory approval of its oral type 2 diabetes medication […]

July 2, 2021 - 5 minutesmins - By Anita Chakraverty

News and Trends 30 Jun 2021

GSK Raises Eyebrows in Checkpoint Inhibitor Megadeal with iTeos

Analysts are abuzz over GSK’s co-development deal with immuno-oncology specialist iTeos Therapeutics earlier this month, wondering if it overpaid for the Belgian company’s next-generation checkpoint inhibitor. GSK’s oncology deal with iTeos earlier this month centered on an antibody drug that blocks an immune checkpoint called TIGIT. The candidate is currently in phase I testing for […]

June 30, 2021 - 5 minutesmins - By Victor Kotsev

Best in Biotech 30 Jun 2021

Scotland’s Top 10 Biotech Companies to Watch Out For

Scotland has a thriving life sciences ecosystem with strengths in oncology, genetic engineering, and industrial biotech. Let’s pick up the bagpipes as we tour the top 10 biotech companies in Scotland. Scotland is the UK’s second-most populous country, boasting picturesque scenery, a rich history, and a strong focus on sustainability. There is a diverse range […]

June 30, 2021 - 11 minutesmins - By Jonathan Smith

In Depth 28 Jun 2021

Transforming Food Waste into Bioenergy

Food waste is one of the many environmental problems caused by modern agriculture. Biotechnology innovations may help us tackle it by turning waste into energy. For decades now, bioenergy has been posited as a renewable and clean source of energy. Biomass, particularly from forestry, is the largest source of renewable energy in the UK. However, […]

June 28, 2021 - 6 minutesmins - By Sachin Rawat

In Depth 23 Jun 2021

How Blockchain Companies Are Helping Us Protect Our Genomic Data

Using genomic data and the blockchain network, it is now possible to send anonymous genetic information around the world in the blink of an eye. Meet the companies that want to help us protect and control our own genetic data. As the cost of sequencing an individual genome falls and more people have access to […]

June 23, 2021 - 7 minutesmins - By Helen Albert

epigenetics oncology car t mnemo therapeutics

News and Trends 22 Jun 2021

Huge Series A in France Strengthens European Epigenetic Oncology

Mnemo Therapeutics has raised €75M in the largest-ever French Series A round, which it will use to develop CAR-T cell immunotherapies for cancer using epigenetic targets. Mnemo Therapeutics’ mammoth financing, led by Casdin Capital, returning investor Sofinnova Partners, and an undisclosed investor, will allow the startup to accelerate the development of its epigenetic targeting and […]

June 22, 2021 - 4 minutesmins - By Laura Cowen

Inside Labiotech 21 Jun 2021

What’s New for Labiotech.eu’s 6th Birthday?

It’s Labiotech’s 6th anniversary! We’re super proud of what we accomplished over the past 6 years and we’d like to thank everyone who contributed to this adventure since our humble beginnings in 2015. Thank you to our team members, freelancers, contributors, and partners—we couldn’t have made it this far without your commitment and support! We’re […]

June 21, 2021 - 3 minutesmins - By Joachim Eeckhout

Opinion 21 Jun 2021

A Window to the Past: Is the Biotech Investment Boom Going to Last?

The biotech industry has been going through a period of fast growth in recent years. To uncover whether the current biotech investment boom will last, let’s look at what history can teach us. A window is something that opens and shuts. So the clear implication of everyone talking about a ‘public market window’ in the […]

June 21, 2021 - 7 minutesmins - By External Contributor

News and Trends 17 Jun 2021

FDA Approval of Biogen’s Drug Boosts European Alzheimer’s Space

The FDA shocked many life sciences observers by greenlighting Biogen’s treatment candidate for Alzheimer’s last week. Yet, for much of the Alzheimer’s disease community on both sides of the Atlantic, the decision also brings cautious hope. Controversy recently erupted when the FDA conditionally granted accelerated approval to Biogen’s aducanumab, making it the first approved treatment […]

June 17, 2021 - 6 minutesmins - By Victor Kotsev

Expert Advice 16 Jun 2021

What Makes a Biotech Executive Stand Out?

Talented executives are always in demand in the biotech industry. Leaders who stand out in the field demonstrate flexibility to deal with change and failure, as well as a track record of hitting milestones. Successful biotechs typically progress along similar paths, moving from small scientist-driven enterprises eager to test their ideas, to established companies with […]

June 16, 2021 - 6 minutesmins - By Mark Zipkin

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Three Lessons an Investor Can Learn from Biotech Entrepreneurs

Why the Right Team is Key for Biotech Success

Poxel’s Diabetes Drug Wins Japan Nod, But Competition Remains Fierce

GSK Raises Eyebrows in Checkpoint Inhibitor Megadeal with iTeos

Scotland’s Top 10 Biotech Companies to Watch Out For

Transforming Food Waste into Bioenergy

How Blockchain Companies Are Helping Us Protect Our Genomic Data

Huge Series A in France Strengthens European Epigenetic Oncology

What’s New for Labiotech.eu’s 6th Birthday?

A Window to the Past: Is the Biotech Investment Boom Going to Last?

FDA Approval of Biogen’s Drug Boosts European Alzheimer’s Space

What Makes a Biotech Executive Stand Out?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!